Literature DB >> 11127271

Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardium.

H W Niessen1, W K Lagrand, H J Rensink, C J Meijer, L Aarden, C E Hack, C Visser.   

Abstract

AIM: To investigate the presence of membrane "flip flop" in ischaemic human myocardium, we assessed depositions of apolipoprotein H (apoH; beta 2-glycoprotein 1) in ischaemic myocardium. Serum protein apoH can bind to negatively charged phospholipids and can also inhibit blood coagulation in vitro. We hypothesised that, because of its affinity for phosphatidyl serine, apoH might bind to "flip flopped" cells and would therefore be useful as a marker for membrane flip flop in vivo.
METHODS: Myocardial tissue specimens were obtained from patients who had died within 14 days of acute myocardial infarction.
RESULTS: Immunohistochemical analysis of these specimens revealed that apoH was selectively deposited in infarcted areas of human myocardium of at least one day's duration. Depositions of apoH were not found in non-ischaemic myocardial tissue samples obtained from patients who died from other (extracardial) causes. In vitro experiments with the human leukaemia T cell line Jurkat, subjected to apoptosis by etoposide, showed that apoH was bound to the membrane of apoptotic cells. However, these experiments also indicated that flip flop itself is not sufficient for apoH binding. In addition, Jurkat cells that bound apoH were positive for activated complement complexes, as was also found in the human heart.
CONCLUSIONS: These results suggest that apoH is involved in the inflammatory processes that occur in ischaemic myocardium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127271      PMCID: PMC1731112          DOI: 10.1136/jcp.53.11.863

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  30 in total

Review 1.  Lipids of mitochondria.

Authors:  G Daum
Journal:  Biochim Biophys Acta       Date:  1985-06-12

2.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

Authors:  M Galli; P Comfurius; C Maassen; H C Hemker; M H de Baets; P J van Breda-Vriesman; T Barbui; R F Zwaal; E M Bevers
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

Review 3.  Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement.

Authors:  A Zachowski
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

Review 4.  ACP Broadsheet No 143: January 1994. Detection of autoantibodies to neutrophil cytoplasmic antigens.

Authors:  R J Lock
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

Review 5.  Flip-flop: the transmembrane translocation of lipids.

Authors:  C F Higgins
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

6.  Improved methods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outer membrane.

Authors:  R Hovius; H Lambrechts; K Nicolay; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1990-01-29

7.  Detection of undiagnosed coeliac disease with atypical features using antireticulin and antigliadin antibodies.

Authors:  R G Watson; S A McMillan; W Dickey; J D Biggart; K G Porter
Journal:  Q J Med       Date:  1992-09

8.  Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.

Authors:  A Väkevä; P Laurila; S Meri
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

9.  Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies.

Authors:  S S Pierangeli; E N Harris; S A Davis; G DeLorenzo
Journal:  Br J Haematol       Date:  1992-11       Impact factor: 6.998

10.  Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.

Authors:  M Segelmark; B Baslund; J Wieslander
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more
  6 in total

1.  IgM colocalises with complement and C reactive protein in infarcted human myocardium.

Authors:  P A J Krijnen; C Ciurana; T Cramer; T Hazes; C J L M Meijer; C A Visser; H W M Niessen; C E Hack
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

2.  C-reactive protein activates complement in infarcted human myocardium.

Authors:  Remco Nijmeijer; Wim K Lagrand; Yvonne T P Lubbers; Cees A Visser; Chris J L M Meijer; Hans W M Niessen; C Erik Hack
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 3.  Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome.

Authors:  Juan J Fierro; Manuela Velásquez; Angela P Cadavid; Karina de Leeuw
Journal:  Am J Reprod Immunol       Date:  2021-12-04       Impact factor: 3.777

Review 4.  The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.

Authors:  Thomas McDonnell; Chris Wincup; Ina Buchholz; Charis Pericleous; Ian Giles; Vera Ripoll; Hannah Cohen; Mihaela Delcea; Anisur Rahman
Journal:  Blood Rev       Date:  2019-08-16       Impact factor: 10.626

5.  The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury.

Authors:  Peng Zhang; James C Weaver; Gang Chen; Julia Beretov; Tatsuya Atsumi; Miao Qi; Ravinay Bhindi; Jian C Qi; Michele C Madigan; Bill Giannakopoulos; Steven A Krilis
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

6.  Comparison of cytokine and gene activities in tissue and blood samples of patients with celiac disease.

Authors:  Ensieh KhalKhal; Zahra Razzaghi; Hakimeh Zali; Ayad Bahadorimonfared; Majid Iranshahi; Mohammad Rostami-Nejad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.